ABG Analytics logo
 

Gilead Sciences Inc (NASDAQ: GILD)

DRUGS - Biotechnology
Sector: Health Care
Stock price data as of 03/15/2024
Closing price: 73.69
Support price level: N/A
Resistance price level: $75.80
Relative strength index (14-day RSI) 54.4
Beta 0.32
  • GILD is at or near its 52-week low. Though contrarian gains may be possible, the risk of further declines is considerable.

  • The price of this low-beta stock is expected to increase by 0.32% for every 1% increase in the S&P-500.

  • Volatility is forecast to fall over the next month.

  • Price broke below prior support level - a short-term bearish signal.

Low High Price as % of Range
$71.58 $87.29 14.6%
200 day 50 day 20 day 10 day
$77.42 $77.33 $73.36 $74.09
(Annualized standard deviation)
Historical
(5 year)
Last month Current estimate Next month forecast
25.8% 26.3% 23.3% 23.8%
There is an estimated 5% probability that the stock price of Gilead Sciences Inc will fall by more than:
  • 6.3% in the next week.

  • 13.5% in the next month.

  • 43.9% in the next year.